Boehringer Ingelheim, a global leader in animal health supports farmers and veterinarians worldwide in their work and promotes better farming practices to achieve long-term, positive impact not only in terms of animal health, but also in terms of well-being. One important way to raise awareness and spread knowledge around animal well-being is to build and share scientific insights on ruminant animal well-being.
“We need more scientific insights on ruminant well-being. That is why we foster research and support young scientists and veterinarians dedicated to ruminant health research. By supporting the veterinary community – be it through awards, sponsorships, or our various customer events we aim to do our part to improve the well-being of ruminant animals worldwide,” notes Gerald Behrens, Head of Ruminant at Boehringer Ingelheim.
Submissions to Ruminant Well-Being Awards open now
In 2018, Boehringer Ingelheim launched the Ruminant Well-Being Awards together with the World Association for Buiatrics (WAB), an independent international association to promote all aspects of buiatrics in both science and practice. The Award is presented in two categories: the Ruminant Well-Being Research Award is granted to a recent PhD graduate in veterinary science, animal science or related disciplines that made an exceptional contribution to the scientific knowledge on ruminant well-being. The Ruminant Well-Being Achievement Award will be awarded to a practicing veterinarian or a researcher in veterinary science, animal science or related disciplines to recognize their achievements in advancing the well-being of ruminants. Applications will be accepted until June 1, 2022. For more information and access to the submission form, please visit: https://farmanimalwellbeing.com/
The winners of the two award categories receive 10,000 EUR each to support their further research. Additionally, Boehringer Ingelheim will reimburse the recipients for travel expenses to attend the World Buiatrics Conference in Madrid, Spain, from September 4-8, 2022. At this key industry event, they will have the opportunity to network with peers and learn about latest developments in bovine veterinary care.
Call for applications for Gustav Rosenberger Memorial Fund (GRMF) grant
Another example of the promotion of young scientists through Boehringer Ingelheim is the sponsoring of the Gustav Rosenberger Memorial Fund (GRMF) grant. The GRMF is a tribute to Dr Gustav Rosenberger and related to the World Association for Buiatrics (WAB). Its objective is to further improve bovine medicine at an international level and to stimulate bovine research in its broadest sense. The GRMF provides grants on a yearly base to young and promising veterinarians who further develop bovine medicine in general. The winner of the GRMF will receive a price money of 10,000 EUR. Candidates for the GRMF grant are veterinarians, working in bovine medicine, and who have graduated no longer than 10 years prior to submitting. Submissions are open now until July 1, 2022. The submission form can be found here: https://gustavrosenberger.com/
Boehringer Ingelheim Animal Health
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 9,700 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.
Respect for animals, humans and the environment is at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases.
Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of 4.1 billion euros in 2020 and presence in more than 150 countries. For more information visit: www.boehringer-ingelheim.com/animal-health.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Learn more at www.boehringer-ingelheim.com.